Marker Therapeutics, Inc.
MRKR
$1.27
$0.086.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 95.45% | 34.12% | 20.93% | 27.01% | -48.50% |
| Total Receivables | 123.70% | -32.76% | 32.80% | 128.32% | 793.64% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -3.40% | -7.64% | -8.26% | -51.05% | -39.55% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 99.21% | 26.49% | 20.59% | 28.58% | -44.01% |
|
|
|||||
| Total Current Assets | 99.21% | 26.49% | 20.59% | 28.58% | -44.01% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 99.21% | 26.49% | 20.59% | 28.58% | -44.01% |
|
|
|||||
| Total Accounts Payable | -12.57% | 109.60% | 7.94% | 10.93% | 63.43% |
| Total Accrued Expenses | -75.74% | 66.23% | 83.54% | 14.92% | 13.74% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 565.52% | 173.22% | -63.38% | -0.10% | -52.11% |
| Total Other Current Liabilities | 565.52% | 173.22% | -63.38% | -0.10% | -52.11% |
| Total Current Liabilities | -3.32% | 116.89% | 8.58% | 12.67% | 24.51% |
|
|
|||||
| Total Current Liabilities | -3.32% | 116.89% | 8.58% | 12.67% | 24.51% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -3.32% | 116.89% | 8.58% | 12.67% | 24.51% |
|
|
|||||
| Common Stock & APIC | 5.60% | 3.42% | 3.44% | 3.38% | 0.10% |
| Retained Earnings | -3.23% | -3.31% | -2.91% | -2.46% | -2.24% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 146.84% | 8.12% | 22.94% | 32.06% | -55.41% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 146.84% | 8.12% | 22.94% | 32.06% | -55.41% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 146.84% | 8.12% | 22.94% | 32.06% | -55.41% |
|
|
|||||